← brief for 2026-10-22 · Slowing decline

Glucagon-like peptide-1 receptor agonists, weight loss, and urolithiasis: what urologists should know.

Article No results yet Peer reviewed

Key takeaways

This review looks at how weight-loss drugs might affect the risk of kidney stones. It summarizes existing studies but does not report new trial results.

Who did this work

Katsimperis S · Tzelves L · Martinez B · Spinos T · Peteinaris A · Pietropaolo A · Skolarikos A

Source

Article · PubMed, the drug frontier · 2026 May 10
https://pubmed.ncbi.nlm.nih.gov/42903630/